109 related articles for article (PubMed ID: 16959607)
1. Mutant p53 gain of function: the NF-Y connection.
Peart MJ; Prives C
Cancer Cell; 2006 Sep; 10(3):173-4. PubMed ID: 16959607
[TBL] [Abstract][Full Text] [Related]
2. Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation.
Di Agostino S; Strano S; Emiliozzi V; Zerbini V; Mottolese M; Sacchi A; Blandino G; Piaggio G
Cancer Cell; 2006 Sep; 10(3):191-202. PubMed ID: 16959611
[TBL] [Abstract][Full Text] [Related]
3. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
4. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
6. Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53.
Chae HD; Yun J; Shin DY
Exp Mol Med; 2005 Oct; 37(5):488-91. PubMed ID: 16264274
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activities of mutant p53: when mutations are more than a loss.
Kim E; Deppert W
J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53: an oncogenic transcription factor.
Strano S; Dell'Orso S; Di Agostino S; Fontemaggi G; Sacchi A; Blandino G
Oncogene; 2007 Apr; 26(15):2212-9. PubMed ID: 17401430
[TBL] [Abstract][Full Text] [Related]
9. Interactions of mutant p53 with DNA: guilt by association.
Kim E; Deppert W
Oncogene; 2007 Apr; 26(15):2185-90. PubMed ID: 17401427
[TBL] [Abstract][Full Text] [Related]
10. A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response.
Benatti P; Basile V; Merico D; Fantoni LI; Tagliafico E; Imbriano C
Nucleic Acids Res; 2008 Mar; 36(5):1415-28. PubMed ID: 18187512
[TBL] [Abstract][Full Text] [Related]
11. The NF-Y/p53 liaison: well beyond repression.
Imbriano C; Gnesutta N; Mantovani R
Biochim Biophys Acta; 2012 Apr; 1825(2):131-9. PubMed ID: 22138487
[TBL] [Abstract][Full Text] [Related]
12. Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells.
Shareef MM; Brown B; Shajahan S; Sathishkumar S; Arnold SM; Mohiuddin M; Ahmed MM; Spring PM
Mol Cancer Res; 2008 Jan; 6(1):89-98. PubMed ID: 18234965
[TBL] [Abstract][Full Text] [Related]
13. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
[TBL] [Abstract][Full Text] [Related]
14. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
Müller GA; Heissig F; Engeland K
Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
[TBL] [Abstract][Full Text] [Related]
15. Transcription regulation by mutant p53.
Weisz L; Oren M; Rotter V
Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
[TBL] [Abstract][Full Text] [Related]
16. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.
Liu K; Ling S; Lin WC
Mol Cell Biol; 2011 Nov; 31(22):4464-81. PubMed ID: 21930790
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53: "gain of function" through perturbation of nuclear structure and function?
Deppert W; Göhler T; Koga H; Kim E
J Cell Biochem Suppl; 2000; Suppl 35():115-22. PubMed ID: 11389540
[TBL] [Abstract][Full Text] [Related]
18. Dual transcriptional control of claudin-11 via an overlapping GATA/NF-Y motif: positive regulation through the interaction of GATA, NF-YA, and CREB and negative regulation through the interaction of Smad, HDAC1, and mSin3A.
Lui WY; Wong EW; Guan Y; Lee WM
J Cell Physiol; 2007 Jun; 211(3):638-48. PubMed ID: 17226765
[TBL] [Abstract][Full Text] [Related]
19. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.
Brazda V; Muller P; Brozkova K; Vojtesek B
Biochem Biophys Res Commun; 2006 Dec; 351(2):499-506. PubMed ID: 17070499
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]